{
    "created_at": "2020-06-07 05:45:08+00:00",
    "id": 1269505652264755200,
    "text": "@88549439 Actually, long QT risk related to plasma concentration. RECOVERY trial loading regime designed to reach the IC50 for SARS-CoV-2 from in vitro studies rapidly, but chronic HCQ treatment for, say, rheumatoid reaches these concentrations but much more slowly.",
    "entities": {
        "mentions": [
            {
                "start": 0,
                "end": 9,
                "username": "88549439",
                "id": "2225226474"
            }
        ]
    },
    "source": "Twitter for iPhone",
    "in_reply_to_user_id": 2225226474
}